This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: University of Cincinnati, Ventana Medical Systems, Inc.. Active years: 2018-2021.
Location History:
- Jazan, SA (2018)
- New Dehli, IN (2021)
Company Filing History:
2 out of 556 
2 out of 548 
Years Active: 2018-2021
Title: Mana Mirza: Innovator in Cancer Prognosis
Introduction
Mana Mirza is a distinguished inventor based in New Delhi, India. He has made significant contributions to the field of cancer research, particularly in the grading and staging of various cancers. With a total of 2 patents, his work has the potential to greatly impact cancer treatment and patient outcomes.
Latest Patents
Mana Mirza's latest patents focus on innovative methods for grading, staging, and prognosing cancer using osteopontin-c. The first patent provides methods and kits that can be utilized to determine the grade or stage of breast cancer or other types of cancer, such as ductal carcinoma in situ (DCIS). By assessing the grade, stage, or aggressiveness of a cancer, healthcare providers can select and administer appropriate therapeutic regimens to patients. The method involves detecting osteopontin-c (OPN-c), where high levels of OPN-c in the cancer sample indicate a more aggressive form of cancer, such as grade 3. This advancement in cancer prognosis is crucial for tailoring effective treatment plans.
Career Highlights
Throughout his career, Mana Mirza has worked with notable organizations, including Ventana Medical Systems, Inc. and the University of Cincinnati. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mana Mirza has had the opportunity to work alongside esteemed colleagues, including Elizabeth Shaughnessy and Georg F Weber. These collaborations have further enriched his research and innovation in cancer prognosis.
Conclusion
Mana Mirza's contributions to cancer research through his patents and collaborations highlight his commitment to improving patient care. His innovative methods for grading and staging cancer are paving the way for more effective treatment strategies.